Comparison of primary patency of radiocephalic and brachiocephalic arteriovenous fistula in East Borneo, Indonesia

Main Article Content

Gratianus Billy Himawan
David Hermawan Christian


arteriovenous fistulae, patency, vascular access, end stage renal disease, hemodialysis


Background: There is still very limited study available for patency of arteriovenous fistulas (AVF) from developing country, specifically in East Borneo, Indonesia. The aim of this study is to compare the primary patency rate between radiocephalic (RC) and brachiocephalic (BC) AVF and to analyze the risk factors involved in the primary patency results of AVF RC and BC for hemodialysis.

Methods: This study is a retrospective cohort study with a total of 154 patients underwent AVF from February 2017 until august 2018 and were monitored until august 2019. The patient’s primary patency of AVF was evaluated by the Kaplan-Meier survival curve. Each of the risk factors that were predicted to influence patency was analyzed for each AVF.

Result: The mean age of 154 patients was 52.9 ± 9.5 years old. RC AVF was made in 130 patients (84.4%) and BC AVF was made in 24 patients (15.6%). There was no significant difference between the estimated primary patency for the RC group and BC AVF, the log-rank test (p=0.15). Risk factors for age, gender, hypertension, DM, and frequency of hemodialysis in both AVF showed statistically insignificant for primary patency.

Conclusion: Our study showed there was no significant difference in the primary patency rate between the RC AVF and BC AVF group and other risk factors not significantly affecting primary patency in either type of AVF.

Abstract 89 | pdf Downloads 67


1. Hill N, Fatoba S, Oke J, Hirst J, O’Callaghan C, Lasserson D et al. Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis. PLOS ONE.2016;11(7).
2. Neuen B, Chadban S, Demaio A, Johnson D, Perkovic V. Chronic Kidney Disease and the Global NCDs Agenda. BMJ Global Health. 2017;2(2).
3. Transl. Dmytro D. Ivanov B. KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 Update. KIDNEYS.2016;0(3.17):53.
4. Ekrikpo U, Udo A, Ikpeme E, Effa E. Haemodialysis in an Emerging Centre in a Developing Country: a Two Year Review and Predictors of Mortality. BMC Nephrology. 2011;12(1).
5. Alecander C, Wolf B, Joss N. A Single- Institution Study of Permanents Vascular Access Outcomes in Patients Undergoing Hemodialysis. Journal of the Association for Vascular Access. 2017;22(2):81-87.
6. Khadatkar A, Mahakalkar C, Pradhan T, Bora A. Comparative Analysis of Radiocephalic Versus Brachiocephalic Native Arteriovenous Fistula for Hemodialysis in End Stage Renal Disease. International Journal of Research in Medical Sciences. 2016;5(1):171.
7. Goh M, Ali J, Iype S, Pettigrew G. Outcome of Primary Arteriovenous Fistula in Patients older than 70 Years. Journal of Vacular Surgery. 2016;63(5):1333-1340.
8. Lammouchi M, Zouaghi M, Hassen M, Rais L, Krid M, Smaoui W et al. Determinants of Patency of Arteriovenous Fistula in Hemodialysis Patients. Saudi Journal of Kidney Diseases and Transplantation. 2018;29(3):615.
9. Zhu Y, Ding H, Fan P, Gu Q, Teng J, Wang W. Predicting the maturity of haemodialysis arteriovenous fistulas with colour Doppler ultrasound: a single-centre study from China. Clinical Radiology. 2016;71(6):576-582.
10. Unger T, Borghi C, Charchar F, Khan N, Poulter N, Prabhakaran D et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020;75(6):1334-1357.
11. Bhattacharyya A. Elderly in India: An Issue of Importance. Advances in Social Sciences Research Journal. 2015;2(6).
12. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2019. Diabetes Care. 2018;42(Supplement 1):S13-S28.
13. Santoro D, Benedetto F, Mondello P, Spinelli F, Ricciardi C, Cernaro V et al. Vascular Access for Hemodialysis: Current Perspectives. International Journal of Nephrology and Renovascular Disease. 2014;281.
14. Erkut B, Calik E, Arslan U. Evaluation of the Factors Affecting the Patency of Arteriovenous Fistulas used for Hemodialysis in End Stage Renal Failure Patients. World J Surg Surgical Res. 2018; 1: 1011.
15. Kim J, Gifford E, Nguyen V, Kaji A, Chisum P, Zeng A et al. Increased use of Brachiocephalic Arteriovenous Fistulas Improves Functional Primary Patency. Journal of Vascular Surgery. 2015;62(2):442-447.
16. Tjang Y, Sumadi G. Primary Patency Rate of Arteriovenous Fistula Created for Hemodialysis Patients: The Indonesian Experience. Journal of the Association for Vascular Access. 2018;23(4):229-233.
17. Lo Z,Tay W, Lee Q, Chua J, Leong Tan G, Chandrasekar S et al. Predictors of Radiocephalic Arteriovenous Fistulae Patency In An Asian Population. The Journal of Vascular Access. 2016;17(5):411-416.

18. Beaulieu, M., Dumaine, C., Romann, A. & Kiaii, M. (2017). Advanced Age Is Not A Barrier To Creating A Functional Arteriovenous Fistula: A Retrospective Study. The Journal of Vascular Access, 18(4), 307-312.
19. KOCAASLAN C, KEHLİBAR T, COŞKUN G, YILMAZ M, ARSLAN Y, GÜNAY R et al. Comparison Primary Failure and Primary Patency Rates of Distal Radiocephalic Arteriovenous Fistulas in Diabetic and Non Diabetic Patients. Turkiye Klinikleri Cardiovascular Sciences. 2015;27(3):88-91.
20. .Diehm, N., Van den BergJ., Schnyder V., Buhler J., Willenberg T., Widmer M., Baumgartner I. Determinants of Haemodialysis Access Survival.Vasa. 2010:133-139.
21. Manne V, Vaddi S, Reddy V, Dayapule S. Factor Influencing Patency of Brescia Cimino Arteriovenous Fistulas in Hemodialysis Patients. Saudi Journal of Kidney Diseases and Transplantation. 2017;28(2):313.
22. Kazemzadeh G., Modaghegh M., Ravari H., Daliri M., Hoseini L., & Nateghi M. Primary Patency Rate of Native AV Fistula: long Term Follow Up. Int J Clin Exp Med, 5(1):173-178.